Pharmaceutical product development
Quality policy
Drug Safety
 
Taficen®
Ekarzin®
Almacor®
 
Financial Reports
Annual Reports
Stock Quotes

Export Brochure
Annual Report 2008 
Quality policy

Increasing turnover and profit at the end of the first semester of 2010

The financial results recorded in the first semester of 2010 confirm the upward trend that Antibiotice has had in the recent years. Thus the net turnover achieved at the end of first half 2010 was ...


USD 20 million exports of medicines for injection Antibiotice Iasi trademark on the U.S. market

On Monday, June 14, Antibiotice made its first delivery of medicines for injection to the U.S. market. For the very first time our company exports finished drugs on this premium market; until now ...



12/08/2010
Summer school a+
16/06/2010
“SUMMER SCHOOL A+” is designed for the future specialists allowing them to complete their university education with a series of concepts, professional standards and ...
More
 
Copyright 2009 Antibiotice SA Toate drepturile rezervate